Loading...
Docoh

PAVmed (PAVM)

PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation. PAVmed's diversified pipeline of products address unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities. Its five lead technologies provide groundbreaking approaches to carpal tunnel syndrome (CarpX™), precancerous conditions of the esophagus (EsoGuard™/EsoCheck™), vascular access (PortIO™), pediatric ear infections (DisappEAR™) and medical infusions (NextFlo™). The company is also developing innovative products in other areas, such as catheters and tissue ablation, while seeking to further expand its pipeline through engagements with clinician innovators and leading academic medical centers.

Company profile

Ticker
PAVM, PAVMZ
Exchange
Website
CEO
Lishan Aklog
Employees
Incorporated
Location
Fiscal year end
Former names
PAXmed Inc.
SEC CIK
Subsidiaries
(PAVmed Inc. • Lucid Diagnostics Inc. • LucidDx Labs Inc. • Veris Health Inc. • Oncodisc Inc • CapNostics LLC • Solys Diagnostics Inc. ...

PAVM stock data

Analyst ratings and price targets

Last 3 months

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

15 Aug 22
4 Oct 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 65.15M 65.15M 65.15M 65.15M 65.15M 65.15M
Cash burn (monthly) (no burn) (no burn) 9.7M 6.84M 7.52M 4.97M
Cash used (since last report) n/a n/a 30.48M 21.49M 23.63M 15.61M
Cash remaining n/a n/a 34.67M 43.66M 41.53M 49.54M
Runway (months of cash) n/a n/a 3.6 6.4 5.5 10.0

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
7 Jun 22 Michael Adam Gordon Employee stock option Common stock Grant Acquire A No No 0.97 400,000 388K 400,000
28 Mar 22 Mcgrath Dennis M Common stock Payment of exercise Dispose F No No 1.18 199,973 235.97K 755,489
28 Mar 22 Aklog Lishan Common stock Payment of exercise Dispose F No No 1.18 79,636 93.97K 176,277
13F holders Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Largest transactions Shares Bought/sold Change

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: ACG, acid, adequate, administer, afforded, aforementioned, AGA, asymptomatic, back, bankrupt, barred, began, bifurcated, biomarker, bone, breach, broader, called, cancellation, cancelled, cavity, circulation, cited, civil, clause, comply, compounded, comprehensive, conferred, consecutive, costly, counsel, credentialing, cured, decided, decrease, defensive, Dr, dysplasia, easy, education, endorsing, endoscopy, EsophaCap, estate, expedient, family, FDCA, foregoing, friendly, furnished, guaranteed, guarantor, guideline, heartburn, host, implicit, importantly, insolvent, interpretation, judicial, lab, LCD, LIMSDx, longer, lowest, mandatory, marrow, Mercury, method, mutual, nondysplastic, nonendoscopic, notification, obesity, object, OCI, offset, online, oversight, payer, pledged, population, premarket, prerequisite, prohibited, race, RCM, recapitalization, recommendation, recommended, recommending, regulation, seminal, sex, simply, smart, smoking, software, Solar, split, standing, straight, symptomatic, thereof, thirty, tobacco, tracking, traditionally, unvested, VWAP, waiver, Warrant, White, widespread, yr
Removed: adversely, anatomic, applied, area, assumed, assuming, authorized, beginning, briefly, California, compression, conjunction, control, covering, curtail, cutting, delayed, delivered, demand, develop, dictated, DisappEAR, disposable, disrupted, distancing, distribution, diversified, divert, downturn, ear, economy, emerging, endoscopic, energy, enrollment, epidemic, established, evaluating, expiration, fluoroscopic, fully, global, glucose, guidewire, headquartered, hospital, identification, imaging, imposed, inability, incision, independent, inflated, infusion, initiation, Innovation, IO, Irvine, launched, ligament, marketed, median, methodology, metropolitan, milestone, mitigate, monitor, national, nerve, NextFlo, opened, operator, Organization, outbreak, partner, partnership, percentage, perform, permanent, Phoenix, positioned, positioning, precautionary, preliminary, pressure, preventive, prioritization, quarantine, Radiofrequency, range, rapidly, reconciliation, relieve, relieving, renewal, repaid, response, sale, separation, significance, site, social, spectrum, spread, strain, supply, telemedicine, tension, tested, Therapy, ultimate, ultrasonic, uncertain, underneath, unmet, UpScriptHealth, vested, wide, wire, World

Patents

Utility
Systems and methods for percutaneous division of fibrous structures
1 Mar 22
A device for dividing a fibrous structure comprising a catheter; an expandable member positioned near a distal end of the catheter and in fluid communication with a lumen of the catheter; and a cutting element situated on an outer surface of the expandable member.
Utility
Systems and Methods for Cell Collection and Protection of Harvested Cells
24 Feb 22
Methods and systems for cell collection.
Utility
Systems and Methods for Percutaneous Division of Fibrous Structures
27 Jan 22
A device for dividing a fibrous structure comprising a catheter; an expandable member positioned near a distal end of the catheter and in fluid communication with a lumen of the catheter; and a cutting element situated on an outer surface of the expandable member.
Utility
Systems and Methods for Percutaneous Division of Fibrous Structures
6 Jan 22
A device for dividing a fibrous structure comprising a catheter; an expandable member positioned near a distal end of the catheter and in fluid communication with a lumen of the catheter; and a cutting element situated on an outer surface of the expandable member.
Utility
Systems and Methods for Minimally-Invasive Division of Fibrous Structures
2 Dec 21
A device for dividing a fibrous structure comprising an expandable member positioned near the distal end of a catheter and in fluid communication with the lumen of the catheter so that the expandable member can be biased between an inflated state and a deflated state to tension the fibrous structure, and electrosurgical elements situated on or proximate to an outer surface of the expandable member and configured to deliver electrical and thermal energy to the tensioned fibrous structure in a manner that results in division of the tensioned fibrous structure.